Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Esketamine for Postoperative Sleep in Cardiac Surgery
NCT06778811Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Oct 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in Postoperative sleep disturbance (PSD) (3 arms), sponsored by Nanjing First Hospital. Primary endpoint: Sleep Quality at 7 days. Started Oct 2024; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06778811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778811.